| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
aryl hydrocarbon receptor nuclear translocator | 0.575 | 0.692 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ASIC4 antisense RNA 1 | 0.931 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||||
|
astrotactin 2 | 0.666 | 0.462 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 5 | 5 | 2017 | 2019 | ||||||||
|
ASTN2 antisense RNA 1 | 0.931 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2019 | 2019 | |||||||||
|
activating transcription factor 1 | 0.588 | 0.577 | 0.63 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2019 | 2019 | ||||||||
|
ataxin 2 | 0.482 | 0.808 | 0.85 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2019 | ||||||||
|
ataxin 7 | 0.581 | 0.654 | 0.96 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
B4GALT1 antisense RNA 1 | 0.792 | 0.192 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
BRISC and BRCA1 A complex member 2 | 0.682 | 0.538 | 0.17 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
BCAR3 adaptor protein, NSP family member | 0.695 | 0.654 | 0.58 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
BCAS3 microtubule associated cell migration factor | 0.716 | 0.538 | 1.4E-04 |
|
phenotype | 0.100 | None | 1.000 | 9 | 8 | 2016 | 2019 | ||||||||
|
BCL2 like 14 | 0.780 | 0.192 | 3.3E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
bridging integrator 3 | 0.931 | 0.115 | 5.8E-13 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2019 | 2019 | ||||||||
|
BLK proto-oncogene, Src family tyrosine kinase | 0.585 | 0.769 | 8.3E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
bone morphogenetic protein 4 | 0.422 | 0.808 | 0.96 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
bromodomain containing 3 | 0.700 | 0.500 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
BTB domain containing 1 | 1.000 | 0.038 | 1.2E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
chromosome 12 open reading frame 4 | 0.691 | 0.308 | 1.1E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
chromosome 2 open reading frame 73 | 3.7E-07 |
|
phenotype | 0.100 | None | 1.000 | 3 | 4 | 2019 | 2019 | ||||||||||
|
complement C9 | 0.619 | 0.692 | 1.6E-24 |
|
phenotype | 0.100 | None | 1.000 | 5 | 7 | 2016 | 2019 | ||||||||
|
carbonic anhydrase 12 | 0.592 | 0.731 | 1.3E-11 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
carbonic anhydrase 3 | 0.682 | 0.500 | 1.7E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
CA3 antisense RNA 1 | 0.890 | 0.308 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
calcium voltage-gated channel subunit alpha1 S | 0.595 | 0.692 | 6.3E-12 |
|
phenotype | 0.100 | None | 1.000 | 5 | 1 | 2016 | 2019 |